Lantheus Holdings, Inc. (LNTH)
76.43
-1.56
(-2.00%)
USD |
NASDAQ |
Mar 20, 16:00
76.41
-0.02
(-0.03%)
After-Hours: 20:00
Lantheus Holdings Research and Development Expense (Quarterly) : 47.48M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Align Technology, Inc. | 83.04M |
| Anika Therapeutics, Inc. | 6.452M |
| BioCryst Pharmaceuticals, Inc. | 40.47M |
| The Cooper Cos., Inc. | 44.30M |
| Iovance Biotherapeutics, Inc. | 71.20M |